NCT00059449已完成不适用
Role of Epidermal Growth Factor (EGF) in Development of Necrotizing Enterocolitis
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)3 个研究点 分布在 1 个国家目标入组 372 人开始时间: 2003年4月29日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 372
- 试验地点
- 3
研究概览
简要总结
Necrotizing enterocolitis (NEC) is a serious gastrointestinal disorder that primarily affects preterm infants. About 10% of babies less than 32 weeks gestation at birth will develop it. Overall, 30% of babies who develop NEC will die from it, with many others developing long term gastrointestinal problems. The most important factor in its development is a premature intestinal tract. Epidermal growth factor (EGF) is an important growth factor in the development and maintenance of the gastrointestinal tract. This study will look for a relationship between EGF levels in premature babies and the development of NEC.
研究设计
- 研究类型
- Observational
- 时间视角
- Prospective
入排标准
- 年龄范围
- — 至 72 Hours（Child）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Gestational Age greater than 23 weeks at birth
- •Birth weight greater than 500 grams
- •Age less than 72 hours of life
排除标准
- 未提供
研究者
研究点 (3)
Loading locations...
相似试验
尚未招募
不适用
Necrotizing Enterocolitis and Bowel Perforation in Very Preterm Infants - Long-term Follow upIntestinal PerforationPremature Infant DiseaseNecrotizing EnterocolitisNCT06757582University Hospital of North Norway150
已完成
1 期
Intestinal Permeability in Preterm InfantsPrematurityIntestinal PermeabilityNCT01756040University of Maryland, Baltimore211
已完成
不适用
Pilot Study of the Feasibility of Feeding Preterm Infants With Fresh Versus Frozen Mother's Own Breast Milk in the NICUNecrotizing EnterocolitisNCT03258957Huiqing Sun100
已完成
不适用
Incidence, Risk Factors, Severity and Prognosis of Necrotizing Enterocolitis in TurkeyNecrotizing EnterocolitisNCT04344639Turkish Neonatal Society500
暂停
不适用
The Effects of Epidermal Growth Factor (EGFR) Inhibition on Pulmonary Arterial Hypertension Associated with Systemic Sclerosis.18-year old patients with systemic sclerosis-associated pulmonary arterial hypertension (SScPAH)NL-OMON27131VU University Medical Center20